Test Bank - Pharmacology: A
Patient-Centered Nursing
Process Approach (12th
Edition, 2025)
PHARMACOLOGY 9TH
EDITION MCCUISTION TEST
BANK
,
, Table of Contents
Table of Contents Chapter 28: Peptides,
Antimalarial, and
Chapter 01: Drug Development and Stabilizers
Ethical Considerations Chapter 24: Antiinflammatories
Chapter 02: Pharmacokinetics, Chapter 25: Analgesics
Pharmacodynamics, and Chapter 26: Antibacterials
Pharmacogenetics Chapter 27: Antituberculars, Antifungals,
Chapter 03: Cultural Considerations and Antivirals
Chapter 04: Complementary and
Alternative Therapies
Chapter 05: Pediatric Considerations
Chapter 06: Geriatric Considerations
Chapter 07: Drugs in Substance Use
Disorder
Chapter 08: The Nursing Process and
Patient-Centered Care
Chapter 09: Safety and Quality
Chapter 10: Drug Administration
Chapter 11: Drug Calculations
Chapter 12: Fluid Volume and
Electrolytes
Chapter 13: Vitamin and Mineral
Replacement
Chapter 14: Nutritional Support Chapter
15: Adrenergic Agonists and Antagonists
Chapter 16: Cholinergic Agonists and
Antagonists
Chapter 17: Stimulants
Chapter 18: Depressants Chapter
19: Antiseizure Drugs
Chapter 20: Drugs for Parkinsonism and
Alzheimer's Disease
Chapter 21: Drugs for Neuromuscular
Disorders and Muscle Spasms Chapter
22: Antipsychotics and Anxiolytics
Chapter 23: Antidepressants and Mood
,Anthelmintic Chapter 55: Adult and Pediatric
Chapter 29: HIV- and AIDS-Related Emergency Drugs
Drugs
Chapter 30: Transplant Drugs
Chapter 31: Vaccines Chapter
32: Anticancer Drugs
Chapter 33: Targeted Therapies to Treat
Cancer
Chapter 34: Biologic Response
Modifiers
Chapter 35: Upper Respiratory
Disorders
Chapter 36: Lower Respiratory
Disorders
Chapter 37: Cardiac Glycosides,
Antianginals, and Antidysrhythmics
Chapter 38: Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants,
Antiplatelets, and Thrombolytics
Chapter 41: Antihyperlipidemics and
Peripheral Vasodilators
Chapter 42: Gastrointestinal Tract
Disorders
Chapter 43: Antiulcer Drugs Chapter
44: Eye and Ear Disorders Chapter 45:
Dermatologic Disorders Chapter 46:
Pituitary, Thyroid, Parathyroid, and
Adrenal Disorders Chapter 47:
Antidiabetics
Chapter 48: Urinary Disorders Chapter
49: Pregnancy and Preterm Labor
Chapter 50: Labor, Delivery, and
Postpartum
Chapter 51: Neonatal and Newborn
Chapter 52: Women's Reproductive
Health
Chapter 53: Men's Reproductive Health
Chapter 54: Sexually Transmitted
Infections
, Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half
of the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection
box. ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-
proprietary. ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic medication
may be given.The patient asks the nurse what this means. What will the nurse tell the patient
about generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
,b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are
marketed. ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs
official name. The nurse understands that this designation indicates the drug
a. is a controlled substance.
, b. is approved by the U.S. Food and Drug Administration (FDA).
c. is available in generic form.
d. meets quality and safety
standards. ANS: D
The USP designation is given to drugs that have met high standards for therapeutic use, patient
safety, quality, purity, strength, packaging safety, and dosage form by the United States
Pharmacopoeia National Formulary. The FDA classifies controlled substances with Roman
numerals from I to V. The USP designation does not indicate FDA approval. The USP
designation does not indicate generic availability.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
5. The nurse is preparing to give a medication to a child. The child’s parent asks whether the
drug is safe for children. How will the nurse respond to the parent?
a. Drugs are tested on adults and safe doses for children are based on weights compared to
adult weights.
b. Drugs are deemed safe for children over time when repeated use proves effectiveness and
safety.
c. Drugs are tested for both efficacy and safety in children in order to be marketed for
pediatric use.
d. Drugs are tested on children in post marketing studies and on a limited
basis. ANS: C
The Pediatric Research Equity Act requires drug manufacturers to test drugs on children.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
6. Which law(s) govern all drug administration by nurses?
a. Drug Regulation and Reform Act
b. FDA Amendments Act
c. Nurse Practice Acts
d. The Controlled Substances Act
ANS: C
Each states Nurse Practice Act identifies how nurses administer medications. The other acts
govern how drugs are marketed and tested.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
Patient-Centered Nursing
Process Approach (12th
Edition, 2025)
PHARMACOLOGY 9TH
EDITION MCCUISTION TEST
BANK
,
, Table of Contents
Table of Contents Chapter 28: Peptides,
Antimalarial, and
Chapter 01: Drug Development and Stabilizers
Ethical Considerations Chapter 24: Antiinflammatories
Chapter 02: Pharmacokinetics, Chapter 25: Analgesics
Pharmacodynamics, and Chapter 26: Antibacterials
Pharmacogenetics Chapter 27: Antituberculars, Antifungals,
Chapter 03: Cultural Considerations and Antivirals
Chapter 04: Complementary and
Alternative Therapies
Chapter 05: Pediatric Considerations
Chapter 06: Geriatric Considerations
Chapter 07: Drugs in Substance Use
Disorder
Chapter 08: The Nursing Process and
Patient-Centered Care
Chapter 09: Safety and Quality
Chapter 10: Drug Administration
Chapter 11: Drug Calculations
Chapter 12: Fluid Volume and
Electrolytes
Chapter 13: Vitamin and Mineral
Replacement
Chapter 14: Nutritional Support Chapter
15: Adrenergic Agonists and Antagonists
Chapter 16: Cholinergic Agonists and
Antagonists
Chapter 17: Stimulants
Chapter 18: Depressants Chapter
19: Antiseizure Drugs
Chapter 20: Drugs for Parkinsonism and
Alzheimer's Disease
Chapter 21: Drugs for Neuromuscular
Disorders and Muscle Spasms Chapter
22: Antipsychotics and Anxiolytics
Chapter 23: Antidepressants and Mood
,Anthelmintic Chapter 55: Adult and Pediatric
Chapter 29: HIV- and AIDS-Related Emergency Drugs
Drugs
Chapter 30: Transplant Drugs
Chapter 31: Vaccines Chapter
32: Anticancer Drugs
Chapter 33: Targeted Therapies to Treat
Cancer
Chapter 34: Biologic Response
Modifiers
Chapter 35: Upper Respiratory
Disorders
Chapter 36: Lower Respiratory
Disorders
Chapter 37: Cardiac Glycosides,
Antianginals, and Antidysrhythmics
Chapter 38: Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants,
Antiplatelets, and Thrombolytics
Chapter 41: Antihyperlipidemics and
Peripheral Vasodilators
Chapter 42: Gastrointestinal Tract
Disorders
Chapter 43: Antiulcer Drugs Chapter
44: Eye and Ear Disorders Chapter 45:
Dermatologic Disorders Chapter 46:
Pituitary, Thyroid, Parathyroid, and
Adrenal Disorders Chapter 47:
Antidiabetics
Chapter 48: Urinary Disorders Chapter
49: Pregnancy and Preterm Labor
Chapter 50: Labor, Delivery, and
Postpartum
Chapter 51: Neonatal and Newborn
Chapter 52: Women's Reproductive
Health
Chapter 53: Men's Reproductive Health
Chapter 54: Sexually Transmitted
Infections
, Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half
of the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection
box. ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-
proprietary. ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic medication
may be given.The patient asks the nurse what this means. What will the nurse tell the patient
about generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
,b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are
marketed. ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs
official name. The nurse understands that this designation indicates the drug
a. is a controlled substance.
, b. is approved by the U.S. Food and Drug Administration (FDA).
c. is available in generic form.
d. meets quality and safety
standards. ANS: D
The USP designation is given to drugs that have met high standards for therapeutic use, patient
safety, quality, purity, strength, packaging safety, and dosage form by the United States
Pharmacopoeia National Formulary. The FDA classifies controlled substances with Roman
numerals from I to V. The USP designation does not indicate FDA approval. The USP
designation does not indicate generic availability.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
5. The nurse is preparing to give a medication to a child. The child’s parent asks whether the
drug is safe for children. How will the nurse respond to the parent?
a. Drugs are tested on adults and safe doses for children are based on weights compared to
adult weights.
b. Drugs are deemed safe for children over time when repeated use proves effectiveness and
safety.
c. Drugs are tested for both efficacy and safety in children in order to be marketed for
pediatric use.
d. Drugs are tested on children in post marketing studies and on a limited
basis. ANS: C
The Pediatric Research Equity Act requires drug manufacturers to test drugs on children.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
6. Which law(s) govern all drug administration by nurses?
a. Drug Regulation and Reform Act
b. FDA Amendments Act
c. Nurse Practice Acts
d. The Controlled Substances Act
ANS: C
Each states Nurse Practice Act identifies how nurses administer medications. The other acts
govern how drugs are marketed and tested.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
